Novartis Bioventures Ltd
CIK 1297709 · last filed 2020-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$29.12M
Companies
11
Total Filings
44
Lifetime Open-Market Net
-$21.96M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Galera Therapeutics, Inc. (GRTX) Delisted | 10%+ Owner | 7,012,340 | $0.14 | $1.02M | -$11.18M | 4 | 2020-06-22 |
| BCYC | 10%+ Owner | 1,769,641 | $4.05 | $7.17M | $4.72M | 1 | 2019-05-30 |
| Whitehawk Therapeutics, Inc. (ARPO) Delisted | 10%+ Owner | 4,188,508 | $33.00 | $138.22M | -$2.89M | 6 | 2019-04-29 |
| Rein Therapeutics, Inc. (ALRN) Delisted | 10%+ Owner | 2,100,004 | $2.11 | $4.43M | -$1.69M | 9 | 2019-04-02 |
| ALT | 10%+ Owner | 8,345,145 | $2.61 | $21.78M | $0 | 8 | 2018-09-14 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | 10%+ Owner | 2,175,314 | $12.01 | $26.13M | -$2.74M | 3 | 2018-05-14 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 2,254,677 | — | — | -$12.06M | 7 | 2017-06-20 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | 10%+ Owner | 4,493,458 | — | — | -$133.7K | 2 | 2015-07-17 |
| AKBA | 10%+ Owner | 182,590 | $0.92 | $168.8K | $3.10M | 1 | 2014-03-27 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | 10%+ Owner | 1,551,721 | — | — | $1.30M | 1 | 2014-02-06 |
| Adhera Therapeutics, Inc. (MRNAD) Delisted | 10%+ Owner | 2,560,565 | — | — | -$383.4K | 1 | 2011-01-27 |
Recent Filings · Page 4 of 5
44 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-08-23 | ALT | Buy (P) | — | $0 | EDGAR |
| 2017-06-20 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −112,840 | -$2.40M | EDGAR |
| 2017-06-08 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −24,228 | -$548.3K | EDGAR |
| 2017-06-02 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −92,522 | -$2.21M | EDGAR |
| 2017-05-30 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −10,706 | -$269.2K | EDGAR |
| 2017-05-25 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −34,902 | -$872.7K | EDGAR |
| 2017-05-18 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −85,230 | -$2.21M | EDGAR |
| 2017-05-02 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Sell (S) | −169,230 | -$3.55M | EDGAR |
| 2017-03-17 | — | Buy (P) | +1,120,000 | $5.60M | |
| 2015-07-17 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Sell (S) | −7,132 | -$101.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.